ResMed EPS Basic from Extraordinaries (Quarterly) Analysis

ResMed, Inc. (RMD)

252.47 +1.55 (+0.62%) USD | NYSE | Jan 09, 16:00

252.51 +0.04 (+0.02%) Pre-Market: 20:00

View EPS Basic from Extraordinaries (Quarterly) for RMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	--
Abbott Laboratories	--
Stryker Corp.	--
West Pharmaceutical Services, Inc.	--
Insulet Corp.	--